Heptares Co-Founder Resigns as VP and CSO of Parent Company Sosei Post author:Sam Post published:January 18, 2018 Post category:BioPharma Dr. Marshall will leave Sosei at the end of February 2018. Source: BioSpace You Might Also Like Capital Increase In Bavarian Nordic As A Result Of Employee Warrant Exercise May 17, 2017 NeuralStem Announces Pricing Of Public Offering Of Common Stock And Warrants July 26, 2017 Five Prime Tanked on Early Peek of Lead Drug Data November 7, 2017
